Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

gekofar s.r.l. - gliclazide - gliclazide

Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

epifarma srl - gliclazide - compresse - " 80 mg compresse " 40 compresse divisibili

Unione Europea - italiano - EMA (European Medicines Agency)

novartis europharm limited - vildagliptin - diabete mellito, tipo 2 - farmaci usati nel diabete - vildagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:as monotherapy in patients in whom metformin is inappropriate due to contraindications or intolerance. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control.

Unione Europea - italiano - EMA (European Medicines Agency)

novartis europharm limited - vildagliptin - diabete mellito, tipo 2 - dipeptidyl peptidase 4 (dpp-4) inhibitors, drugs used in diabetes - vildagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:as monotherapy in patients in whom metformin is inappropriate due to contraindications or intolerance. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 e 5. 1 per i dati disponibili su diverse combinazioni).